التفاصيل البيبلوغرافية
| العنوان: |
Increased incidence of glaucoma medication usage in middle-aged Australian males taking antiretroviral medication – a population-based study. |
| المؤلفون: |
Lee, Wen-Shen, Parsons, Shaun, Cugley, Dean, Rogers, Sophie, Lim, Lyndell L., Hall, Anthony |
| المصدر: |
Journal of Ophthalmic Inflammation & Infection; 11/3/2020, Vol. 10 Issue 1, pN.PAG-N.PAG, 1p |
| مصطلحات موضوعية: |
OPEN-angle glaucoma, GLAUCOMA, ANTIRETROVIRAL agents, AUSTRALIANS, HIV, HIV infections |
| مستخلص: |
Background: To investigate a possible association between glaucoma and the use of anti-retroviral therapy (ART) for HIV in the Australian population. Methods: A retrospective review of Australian Pharmaceutical Benefits Scheme data was undertaken from July 2012 to December 2016, inclusive. Three patient groups were compared: those on both topical intraocular pressure (IOP) -lowering medication and ART, those on ART only, and those on IOP-lowering medication only, using the 2016 Australian resident population to estimate prevalence. Odds ratios (95% confidence intervals, [CI]) with Fishers exact test for p values were calculated stratified by age and gender. Results: The number of prescriptions for topical glaucoma medications in the general Australian population increased progressively by age with a peak prevalence in those aged 80 years and above. Prevalence of ART was highest in males aged 40–49 and 50–59 years (0.41% [CI 0.40, 0.42] and 0.44% [CI 0.43, 0.45], respectively). Our analysis identified an increase in the prescription of IOP-lowering medication in males on ART aged 30–39 (OR 2.23 [CI 1.32, 3.75], p = 0.007) and 40–49 (OR 1.86 [CI 1.42, 2.43], p < 0.001), compared to those not on ART. There were no statistically significant increased odds for females or males aged 50 years or more. Conclusion: Compared with the known increase in glaucoma prevalence with age in the general Australian population, a statistically significant increased prevalence in use of IOP-lowering medications was found in males on ART aged 30–49 years. The mechanism for this is yet to be determined, but possible causes include sequelae of HIV infection, a drug-induced side effect, or increased medical surveillance. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Ophthalmic Inflammation & Infection is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Find this article in full text from Springer Verlag. 
Full Text Finder